摘要:
The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of treating pain using these compounds and pharmaceutical compositions including these compounds.
摘要:
The isoquinoline compounds of formula (I) are VR1 antagonists that are useful in treating pain, inflammation, thermal hyperalgesia, urinary incontinence and bladder over activity. The “R”, “Z” and “L” variables are defined in the disclosure and the “X” variables are defined as follows: X1 is CR1; X2 is selected from the group consisting of N and CR2; X3 is selected from the group consisting of N and CR3; X4 is CR4; and X5 is selected from the group consisting of N and C.
摘要翻译:式(I)的异喹啉化合物是可用于治疗疼痛,炎症,热痛觉过敏,尿失禁和膀胱过度活动的VR1拮抗剂。 在本公开中定义了“R”,“Z”和“L”变量,“X”变量定义如下:X 1是CR 1 1。 X 2选自N和CR 2; X 3选自N和CR 3; X 4是CR 4; 并且X 5选自N和C。
摘要:
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2 and L are as defined in the description.
摘要:
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2 and L are as defined in the description.
摘要翻译:式(I)化合物是可用于治疗疼痛,炎症性热痛觉过敏,尿失禁和膀胱过度活动的新型VR1拮抗剂,其中X 1,X 2,X 2, X 3,X 4,X 5,R 5,R 6,R 6, Z 7,R 8a,R 8b,R 9,Z 1,Z 3, SUB> 2>和L如说明书中所定义。
摘要:
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2, and L are defined in the description.
摘要翻译:式(I)化合物是可用于治疗疼痛,炎症性热痛觉过敏,尿失禁和膀胱过度活动的新型VR1拮抗剂,其中X 1,X 2,X 2, X 3,X 4,X 5,R 5,R 6,R 6, Z 7,R 8a,R 8b,R 9,Z 1,Z 3, SUB> 2>和L如说明书中所定义。
摘要:
The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of trating pain using these compounds and pharmaceutical compositions including these compounds.
摘要:
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
摘要:
The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of treating pain using these compounds and pharmaceutical compositions including these compounds.